Navigation Links
Chemotherapy effective for patients with resected SCLC or large-cell neuroendocrine carcinoma
Date:6/15/2012

DENVER Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroendocrine tumors or with limited stage small-cell lung cancer who were treated with perioperative chemotherapy and surgery had better overall survival outcomes than patients treated with surgery alone.

Small-cell lung cancer (SCLC) represents about 15 percent of lung cancers annually. Of those, about 30 percent of patients have limited disease SCLC. Whereas large-cell neuroendocrine carcinoma (LCNEC) is a subgroup of large-cell carcinoma, that has characteristics similar to SCLC. Surgery in these groups of patients are rare and researchers wanted to know if perioperative chemotherapy would benefit the patients.

The retrospective study looked at 74 patients who underwent lung cancer surgery at the Surgical Centre Marie Lannelongue in Le Plessis Robinson, France between 1979 and 2007. Forty-five patients underwent surgery combined with perioperative chemotherapy and 29 underwent surgery alone. They found, "treatment involving surgery plus perioperative chemotherapy was associated with a significantly longer OS (overall survival) than surgery alone (6.1 years and 2.3 years, respectively)."

The authors point out that there were limitations to their study. Because the data was from 1979, the previous staging system was used. The authors also point out that, "more patients had a node involvement in the chemotherapy group, indicating that physicians may have offered chemotherapy to patients with more advanced disease." However, no conclusion could be made because of the, "small population examined in this study, its retrospective nature, the difference in follow-up between the two groups and the heterogeneity of the combined treatments."

The authors point out that due to the rarity of this population, a prospective trial is unlikely to be feasible and these retrospective data may be of value.


'/>"/>

Contact: Kristal Griffith
Kristal.Griffith@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer
Source:Eurekalert

Related medicine news :

1. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
2. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
3. Genetic predictor of breast cancer response to chemotherapy
4. Chemotherapys effect on overall survival seems to increase based on tumor size
5. Accelerated chemotherapy given before surgery benefits patients with muscle-invasive bladder cancer
6. Breast MRI helps predict chemotherapys effectiveness
7. Why chemotherapy fails
8. Overexpression of proteins 14-3-3 related to chemotherapy resistance
9. HIV Prevention Pill Cost-Effective for High-Risk Men: Study
10. Pig stomach mucins are effective as anti-viral agents for consumer products
11. Lower-Dose Radioiodine Effective Against Thyroid Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... Dr. Richard Amato, a ... of his practice, Advanced Periodontics and Dental Implant Center of Connecticut. As part of ... and waiting areas. The renovations are intended to improve patient comfort while making it ...
(Date:6/27/2017)... ... 2017 , ... Children’s National Health System received top honors in the 2017-18 ... #1 out of more than 1500 neonatal intensive care units coast to coast. ... distinction given to the top performing children’s hospitals in the country. , In ...
(Date:6/26/2017)... ... 26, 2017 , ... Maryland’s soybean farmers have improved the ... by the United Soybean Board. , Thanks to the responsible use of ... productivity on less land per bushel, the report says. The United Soybean Board’s ...
(Date:6/26/2017)... ... ... New patients with missing teeth in Fitchburg, WI, can now ... Cotey is a trusted dentist who has placed many dental implants and enjoys teaching ... teeth in Fitchburg, WI, are encouraged to find out if they are candidates for ...
(Date:6/25/2017)... Orleans (PRWEB) , ... June 25, 2017 , ... CareSet ... Meeting in New Orleans. This is a new, greatly improved version of the ... Information Act (FOIA) requests by Fred Trotter and subsequently called the the “Doctor Referral ...
Breaking Medicine News(10 mins):
(Date:5/30/2017)... CAESAREA, Israel , May 30, 2017 DarioHealth Corp. ... and big data solutions, today announced that it will be presenting ... 2017, at 8:00 AM PT. Erez Raphael , CEO, of ... The conference will be held on June 6th & 7th, ... 180 companies in the small / micro-cap space. ...
(Date:5/26/2017)... plc (NASDAQ: ENDP ) announced today that ... in a fireside chat at Goldman Sachs, 38 th ... 10:40 a.m. PT / 1:40 p.m. ET. The conference will ... Verdes, CA. A live webcast and ... Company,s website at http://www.endo.com/investors/overview . Participants should allow approximately ...
(Date:5/22/2017)... , May 22, 2017  Lilac Corp, ... Gene-Eden-VIR/Novirin, announces the launch of a new ... the results of a clinical study that showed ... treatment with Gene-Eden-VIR/Novirin in individuals suffering from HPV ... note that there are no other treatments that ...
Breaking Medicine Technology: